Clinical observation of Edaravone in the treatment of 44 patients with cerebral infarction
Shixiu Wang
Abstract
Shixiu Wang
Abstract
Objective:To observe the efficacy and adverse reactions of Edaravone in the treatment of cerebral infarction.Methods:60 patients with acute cerebral infarction were randomly divided into two groups,20 cases of the control group were treated by routine therapy,the experimental group added Edaravone,after 2 weeks,we evaluated the efficacy.Results:The experimental group has obvious effects and less adverse reactions.Conclusion:Edaravone in the treatment of acute cerebral infarction is safe and effective.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To observe the efficacy and adverse reactions of Edaravone in the treatment of cerebral infarction.Methods:60 patients with acute cerebral infarction were randomly divided into two groups,20 cases of the control group were treated by routine therapy,the experimental group added Edaravone,after 2 weeks,we evaluated the efficacy.Results:The experimental group has obvious effects and less adverse reactions.Conclusion:Edaravone in the treatment of acute cerebral infarction is safe and effective.
Key concepts: Edaravone, Medicine, Cerebral infarction, Clinical efficacy, Adverse effect, Anesthesia, Conventional treatment, Brain infarction